Statins and type 2 diabetes: genetic studies on target.

doi:10.1016/S0140-6736(14)61639-1

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Statins and type 2 diabetes: genetic studies on target.

Lancet (London, England) - 24 Jan 2015

Frayling Timothy M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Weight
Share to Diabetes Mellitus, Type 2
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors
Share to Hydroxymethylglutaryl CoA Reductases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 25262342
DOI: 10.1016/S0140-6736(14)61639-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Statins and type 2 diabetes: genetic studies on target.PMID 25262342Read ↗

Pharmacogenetic study of statin therapy and cholesterol reduction.Semantic proximity Read ↗

Genetics and personalized medicine--a role in statin therapy?Semantic proximity Read ↗

Clinical implications of pharmacogenomics of statin treatmentSemantic proximity Read ↗

Genetic contribution to lipid target achievement with statin therapy: a prospective study.Semantic proximity Read ↗

Statins personalized.Semantic proximity Read ↗

The pharmacogenomics of statins.Semantic proximity Read ↗

Genetic effects on efficacy of lipid-lowering drugs.Semantic proximity Read ↗

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.Semantic proximity Read ↗

Genetic determinants of response to statins.Semantic proximity Read ↗

Pharmacogenomics, lipid disorders, and treatment options.Semantic proximity Read ↗

Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment.Semantic proximity Read ↗

Statin-induced diabetes: incidence, mechanisms, and implicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.